| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |